fusaric acid has been researched along with Abnormalities, Drug-Induced in 1 studies
Fusaric Acid: A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuzaki, M | 1 |
| Akutsu, S | 1 |
| Mukogawa, H | 1 |
| Shimamura, T | 1 |
1 other study available for fusaric acid and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
[Teratological studies of fusaric acid-Ca in mice and rats (author's transl)].
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Bone and Bones; Female; Fetus; Fusaric Acid; Inte | 1976 |